Tumor Updates: Oligodendrioglioma
https://www.ncbi.nlm.nih.gov/pubmed/26530260
https://www.ncbi.nlm.nih.gov/pubmed/29205287
https://www.ncbi.nlm.nih.gov/pubmed/29143276 https://www.ncbi.nlm.nih.gov/pubmed/28640702 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735229/
https://www.ncbi.nlm.nih.gov/pubmed/28640702
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735229/
Anaplastic Oligodendroglioma: A New Treatment Paradigm and Current Controversies.
LOH 19q indicates shorter disease progression-free interval in low-grade oligodendrogliomas with EMP3 methylation.
Oligodendrogliomas: new insights from the genetics and perspectives.